 <h1>Rinvoq Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>upadacitinib</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about upadacitinib. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Rinvoq.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to upadacitinib: oral tablet extended release</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet, Extended Release)</p><p>Serious infections leading to hospitalization or death, including tuberculosis and bacterial, invasive fungal, viral, and other opportunistic infections, have occurred. If a serious infection develops, interrupt upadacitinib until the infection is controlled. Prior to starting upadacitinib, perform a test for latent TB; if it is positive, start treatment for TB prior to starting upadacitinib. Monitor all patients for active TB during treatment, even if the initial latent tuberculosis test is negative. Lymphoma and other malignancies have been observed in patients treated with upadacitinib. Thrombosis, including deep vein thrombosis, pulmonary embolism, and arterial thrombosis, have occurred in patients treated with Janus kinase inhibitors used to treat inflammatory conditions</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, upadacitinib (the active ingredient contained in Rinvoq) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking upadacitinib:</p><p>
<i>More common</i>
</p><ul>
<li>Body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>ear congestion</li>
<li>fever</li>
<li>headache</li>
<li>itching, pain, redness, swelling, tenderness, warmth on the skin</li>
<li>loss of voice</li>
<li>runny or stuffy nose </li>
<li>sneezing</li>
<li>sore throat</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>burning or stinging of the skin</li>
<li>lower back or side pain</li>
<li>painful blisters on the trunk of the body</li>
<li>painful cold sores or blisters on the lips, nose, eyes, or genitals</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>ulcers, sores, or white spots in the mouth or tongue</li>
<li>unusual bleeding or bruising</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Coughing or spitting up blood</li>
<li>difficulty with breathing</li>
<li>heartburn</li>
<li>indigestion</li>
<li>muscle aches</li>
<li>nausea</li>
<li>night sweats</li>
<li>pale skin</li>
<li>persistent non-healing sore</li>
<li>pink growth</li>
<li>reddish patch or irritated area</li>
<li>severe abdominal or stomach pain, cramping, or burning</li>
<li>shiny bump</li>
<li>sudden high fever or low-grade fever for months</li>
<li>troubled breathing with exertion</li>
<li>vomiting of material that looks like coffee grounds, severe and continuing</li>
<li>white, yellow or waxy scar-like area</li>
</ul><p>
<!-- end oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to upadacitinib: oral tablet extended release</i></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Neutropenia, lymphopenia, anemia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Herpes zoster, herpes simplex (includes oral herpes), oral candidiasis</p>
<p><b>Frequency not reported</b>: Tuberculosis (TB), cellulitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased lipids<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver enzyme elevation<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Non-melanoma skin cancer<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (e.g., acute sinusitis, laryngitis, nasopharyngitis, oropharyngeal pain, pharyngitis, pharyngotonsillitis, rhinitis, sinusitis, tonsillitis, viral upper respiratory tract infection) (14%)</p>
<p><b>Common</b> (1% to 10%): Cough</p>
<p><b>Frequency not reported</b>: Pneumonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pyrexia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Thrombosis (e.g., deep venous thrombosis), pulmonary embolism, arterial thrombosis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: GI perforation<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Rinvoq (upadacitinib)." AbbVie US LLC, North Chicago, IL. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What are the new drugs for the treatment of rheumatoid arthritis (RA)?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Rinvoq (upadacitinib)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>28 Reviews</li>
<li>Drug class: antirheumatics</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Rinvoq &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Rheumatoid Arthritis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to upadacitinib: oral tablet extended release</i></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Neutropenia, lymphopenia, anemia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Herpes zoster, herpes simplex (includes oral herpes), oral candidiasis</p><p><b>Frequency not reported</b>: Tuberculosis (TB), cellulitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased lipids<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Frequency not reported</b>: Liver enzyme elevation<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Non-melanoma skin cancer<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (e.g., acute sinusitis, laryngitis, nasopharyngitis, oropharyngeal pain, pharyngitis, pharyngotonsillitis, rhinitis, sinusitis, tonsillitis, viral upper respiratory tract infection) (14%)</p><p><b>Common</b> (1% to 10%): Cough</p><p><b>Frequency not reported</b>: Pneumonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Pyrexia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Thrombosis (e.g., deep venous thrombosis), pulmonary embolism, arterial thrombosis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Frequency not reported</b>: GI perforation<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Rinvoq (upadacitinib)." AbbVie US LLC, North Chicago, IL. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are the new drugs for the treatment of rheumatoid arthritis (RA)?</li>
</ul><h2>More about Rinvoq (upadacitinib)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>28 Reviews</li>
<li>Drug class: antirheumatics</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Rinvoq &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Rheumatoid Arthritis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>